Chronic lymphocytic leukemia (CLL) patients at a VA medical center: Comorbidity and survival.

被引：0
|
作者：
Soriano, L.
Srinivas, S.
Tufail, M.
Kim, K.
Paulin, R.
Chang, V. T.
Kasimis, B.
Gonzalez, M. L.
机构：
[1] UMDNJ New Jersey Med Sch, Newark, NJ USA
[2] VA New Jersey Hlth Care Syst, E Orange, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6602
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect® CLL Disease Registry
    Sharman, Jeff
    Flowers, Christopher R.
    Weiss, Mark
    Grinblatt, David
    Farber, Charles
    Kay, Neil
    Kipps, Thomas
    Lamanna, Nicole
    Pashos, Chris
    Flinn, Ian W.
    Kozloff, Mark
    Lerner, Susan
    Swern, Arlene S.
    Sullivan, Kristen A.
    Street, Thomas K.
    Keating, Michael
    BLOOD, 2011, 118 (21) : 1235 - 1236
  • [42] Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
    Nistico, Nancy
    Maisano, Domenico
    Iaccino, Enrico
    Vecchio, Eleonora
    Fiume, Giuseppe
    Rotundo, Salvatore
    Quinto, Ileana
    Mimmi, Selena
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 14
  • [43] Conditional survival in patients with chronic lymphocytic leukemia
    Schiwitza, A.
    Schlosser, P.
    Klaus, J.
    Hieke, S.
    Szic, K. Szarc Vel
    Hild, S.
    Gumpp, V.
    Duyster, J.
    Zirlik, K.
    Schumacher, M.
    Claus, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 120 - 120
  • [44] Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL)
    Del Poeta, Giovanni
    Dal Bo, Michele
    Buccisano, Francesco
    Pozzo, Federico
    Del Principe, Maria Ilaria
    Bulian, Pietro
    Rossi, Davide
    Venditti, Adriano
    de Fabritiis, Paolo
    Gaidano, Gianluca
    Amadori, Sergio
    Gattei, Valter
    BLOOD, 2015, 126 (23)
  • [45] Targeted Agents in Chronic Lymphocytic Leukemia (CLL): Advancements in Overall Survival Outcomes?
    Molica, Stefano
    Shanafelt, Tait D.
    Allsup, David
    Giannarelli, Diana
    BLOOD, 2023, 142
  • [46] Survival outcomes after initial infused therapy for elderly chronic lymphocytic leukemia (CLL) patients.
    Danese, M.
    Griffiths, R.
    Gleeson, M.
    Satram-Hoang, S.
    Knopf, K. B.
    Mikhael, J.
    Reyes, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] The effect of initial therapy choice in determining long term survival in patients with chronic lymphocytic leukemia (CLL).
    Tam, Constantine S.
    Wen, Sijin
    Do, Kim-Anh
    Lerner, Susan
    Wierda, William G.
    O'Brien, Susan
    Keating, Michael J.
    BLOOD, 2006, 108 (11) : 332B - 332B
  • [48] Relapse treatment of chronic lymphocytic leukemia (CLL)
    Eichhorst, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 266 - 266
  • [49] CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - TREATMENT
    ROZMAN, C
    MONTSERRAT, E
    BONE MARROW TRANSPLANTATION, 1989, 4 : 159 - 161
  • [50] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
12345